Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Neu

Showing results (91-100 of 505) with videos related to

Pageof 51
Sort By:
Journal of Clinical Pharmacology|March 1, 1985
Antimicrobial pharmacology: is it possible to use antibiotics cost-effectively with attention to antimicrobial activity, bacterial resistance, and the pharmacologic properties of the agents?H C Neu
Infectious Disease Clinics of North America|September 1, 1989
The quinolonesH C Neu
Bulletin of the New York Academy of Medicine|April 1, 1987
The biochemical basis of antimicrobial and bacterial resistanceH C Neu
The Journal of Antimicrobial Chemotherapy|July 1, 1985
The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolonesH C Neu
Comprehensive Therapy|February 1, 1976
The changing ecology of bacterial infections in childrenH C Neu
Infection|January 1, 1992
Optimal characteristics of agents to treat uncomplicated urinary tract infectionsH C Neu
Drugs|January 1, 1987
Cephalosporins in the treatment of meningitisH C Neu
American Journal of Surgery|May 31, 1988
Cephalosporin antibiotics: molecules that respond to different needsH C Neu
The Medical Clinics of North America|January 1, 1982
Antistaphylococcal penicillinsH C Neu
The American Journal of Medicine|April 6, 1992
Urinary tract infectionsH C Neu
Pageof 51

Showing results (91-100 of 505) with videos related to

Sort By:
Pageof 51
Journal of Clinical Pharmacology|March 1, 1985
Antimicrobial pharmacology: is it possible to use antibiotics cost-effectively with attention to antimicrobial activity, bacterial resistance, and the pharmacologic properties of the agents?H C Neu
Infectious Disease Clinics of North America|September 1, 1989
The quinolonesH C Neu
Bulletin of the New York Academy of Medicine|April 1, 1987
The biochemical basis of antimicrobial and bacterial resistanceH C Neu
The Journal of Antimicrobial Chemotherapy|July 1, 1985
The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolonesH C Neu
Comprehensive Therapy|February 1, 1976
The changing ecology of bacterial infections in childrenH C Neu
Infection|January 1, 1992
Optimal characteristics of agents to treat uncomplicated urinary tract infectionsH C Neu
Drugs|January 1, 1987
Cephalosporins in the treatment of meningitisH C Neu
American Journal of Surgery|May 31, 1988
Cephalosporin antibiotics: molecules that respond to different needsH C Neu
The Medical Clinics of North America|January 1, 1982
Antistaphylococcal penicillinsH C Neu
The American Journal of Medicine|April 6, 1992
Urinary tract infectionsH C Neu
Pageof 51